Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
December 29, 2023
What a year! Perspectives has explored a myriad of topics this year within clinical development — from adaptive trial...
Read article
December 22, 2023
Top Therapeutics Development Topics of 2023
Perspectives covers a wide range of topics within therapeutics development from advice on regulatory submission to...
Read article
January 23, 2023
Design Considerations for Early Phase Trials of Immuno-oncology Drugs
Ever since the first immune checkpoint inhibitor was approved for market nearly twelve years ago, the industry has...
Read article
April 7, 2021
Career Perspectives: Interview with Neha Sati
Scientists at Cytel recently published a paper in the Journal of the American Medical Association (JAMA). Among the...
Read article
September 17, 2018
Novel immunotherapies lean on old methods
Immunotherapy has brought us many promises, most notably, of a future where humans are able to harness their body’s own...
Read article